Genelux

(NASDAQ) GNLX

Current Price$3.17

Market Cap$126.80M

Since IPO (2023)-54%

5 YearN/A

1 Year+22%

1 Month+7%

Genelux Financials at a Glance

Market Cap

$126.80M

Revenue (TTM)

$8.00K

Net Income (TTM)

$33.58M

EPS (TTM)

$-0.87

P/E Ratio

-3.27

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$3.17

Volume

2,732

Open

$2.83

Price

$3.17

Volume

2,732

Open

$2.83

Previous Close

$2.83

Daily Range

$2.83 - $3.17

52-Week Range

$2.29 - $8.54

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$3.17

Volume

2,732

Open

$2.83

Previous Close

$2.83

Daily Range

$2.83 - $3.17

52-Week Range

$2.29 - $8.54

GNLX News

scientist viewing bacteria test gloves petri dish

Why Shares of Genelux Climbed This Week

James HalleyJul 28, 2023

Why Shares of Genelux Corporation Jumped This Week

James HalleyJun 1, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genelux

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thomas D. Zindrick

Website

www.genelux.com

Headquarters

Westlake Village, CA 91361, US

GNLX Financials

Key Financial Metrics (TTM)

Gross Margin

-35%

Operating Margin

-3175%

Net Income Margin

-4198%

Return on Equity

-170%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-30.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$126.80M

Shares Outstanding

44.81M

Volume

2.73K

Avg. Volume

185.90K

Financials (TTM)

Gross Profit

$566.00K

Operating Income

$33.21M

EBITDA

$32.64M

Operating Cash Flow

$25.27M

Capital Expenditure

$1.10M

Free Cash Flow

$26.37M

Cash & ST Invst.

$14.60M

Total Debt

$1.69M

Genelux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$126.80M

N/A

Market Cap/Employee

$5.28M

N/A

Employees

N/A

Net Income

$8.93M

-19.2%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$23.71M

-28.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.18M

+50.3%

Short Term Debt

$316.00K

-6.2%

Return on Assets

-1.04%

N/A

Return on Invested Capital

-1.01%

N/A

Free Cash Flow

$6.98M

-27.7%

Operating Cash Flow

$6.06M

-11.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALDXAldeyra Therapeutics, Inc.

ALDXAldeyra Therapeutics, Inc.$1.74+0.58%

MREOMereo BioPharma Group plc

MREOMereo BioPharma Group plc$0.24-0.58%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.81-3.94%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$7.03+1.15%

CLLSCellectis S.A.

CLLSCellectis S.A.$3.94+2.07%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$5.72-1.72%

CADLCandel Therapeutics, Inc.

CADLCandel Therapeutics, Inc.$8.06+3.53%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.59+0.08%

RXTRackspace Technology

RXTRackspace Technology$4.99+0.42%

NOKNokia

NOKNokia$12.87+0.04%

OPENOpendoor Technologies

OPENOpendoor Technologies$5.06-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.45-0.05%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$7.62+0.20%

IRENIren

IRENIren$60.87+0.07%

Questions About GNLX

What is the current price of Genelux?

Genelux is trading at $3.17 per share.

What is the 52-week range for Genelux?

Over the past 52 weeks, Genelux has traded between $2.29 and $8.54.

How much debt does Genelux have?

As of the most recent reporting period, Genelux reported total debt of $1.69M.

How much cash does Genelux have on hand?

Genelux reported $5.33M in cash and cash equivalents in its most recent financial results.

What is Genelux’s dividend yield?

Genelux does not currently have a dividend yield.

Genelux

Genelux Financials at a Glance

GNLX News

Why Shares of Genelux Climbed This Week

Why Shares of Genelux Corporation Jumped This Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Genelux

GNLX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Genelux Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GNLX

What is the current price of Genelux?

What is the 52-week range for Genelux?

How much debt does Genelux have?

How much cash does Genelux have on hand?

What is Genelux’s dividend yield?

Premium Investing Services